Pulses and Oilseeds Grain-Free Pet Food for Cats and Dogs
 
Formulation Precision Innovation in Pet Food

4+ MIN

Precision Innovation in Pet Food

By Armando Enriquez de la Fuente Blanquet


Latest content from Macro Ingredients

From Claim to Credibility: The Case for Research-Backed Pet Food Ingredients
Formulation

4+ MIN

From Claim to Credibility: The Case for Research-Backed Pet Food Ingredients

The pet food industry is unique in that of all the 602 standard pet food ingredients used today, 44% of them are upcycled, which means that they are derived from animal and plant sources that would not be used in human food. This makes pet food a great source to utilize ingredients that otherwise would be wasted, and reduces the competition between human food and pet food for ingredients that span both categories.
  This becomes increasingly important as currently 9% of the world's population is considered hungry, according to a recent report by the World Health Organization. Unfortunately, these upcycled ingredients may not be viewed as premium ingredients by consumers who have decided that descriptions such as 'by-product' are not good for their pets. Many times, these decisions are not based on nutritional research but on messaging from pet food companies. Starches, flours, and functional dietary fibers have been described by many pet food brands as 'fillers,' when there actually is no definitive or regulatory definition for that term. In most cases, these ingredients not only provide nutritional value for pets but also deliver functional benefits that make the pet food easier to actually manufacture.   
  New pet food ingredients and categories have become more popular. The pet food protein category has seen many new entries and continues to see new types of proteins entering the market. Examples of these proteins include cultured meat, insect-based, bacteria- and yeast-based cultures, and upcycled food ingredients. All these new and novel pet food proteins collectively have the potential to help decrease the competition of using animal-based proteins in pet food that could be used in the human food supply. Each one has valid reasons for use, including sustainability, low carbon footprint, as well as delivering needed alternative protein sources for pet food in a competitive landscape. 
  Beyond protein, it is well accepted that Omega-3 fatty acids can help deliver benefits such as skin and coat support, joint health, cognitive health, as well as immune benefits to pets. Most of the Omega-3 fatty acids in pet food, such as EPA and DHA, come from fish oil. As with animal protein ingredients, there is higher competition for fish oil products in human goods when compared to pet food and pet supplement use. Microalgae products have become more prevalent in the pet food world, being described as more sustainable alternatives to fish oil and helping to decrease the reliance on fish oil to deliver the health benefits of Omega-3 fatty acids. 
  Another new trend in the past few years is the promotion of postbiotics. These are inactivated microorganisms, such as yeast or bacteria, and their components that are released after probiotics are no longer alive, which have many health benefits, including digestive health, immune support, and even oral health benefits for pets. Another claimed benefit is that they do not require live bacteria like probiotics do, which may make them more user-friendly in pet food manufacturing.
  These are all examples of new pet food ingredients and categories. Many of these novel pet food ingredients have the potential to help deliver functional benefits to our pets, as well as contribute to the sustainability of the pet food industry as a whole. However, when it comes to the business of the pet food industry, there is a lot of competition in the ingredient space. Many of these newer ingredients come at a premium price when compared to their traditional ingredient counterparts. This means that even though pet food brands may want to use them in products because of the benefits and claims they provide, they have to be affordable and must deliver value that the pet food company and consumer understand. 
  A good way to determine the value of an ingredient is by looking at the extent of research that has been done by the ingredient company to substantiate the claims they promote. Pet food ingredient companies should be conducting feeding study research to validate the claims they make. In vitro (laboratory) studies are helpful for screening tests. However, to actually demonstrate ingredient value, the pet food ingredient industry should be conducting feeding studies to show health benefits in pets. Long-term feeding studies using new ingredients and measuring health parameters are sorely needed to gain credibility for ingredient companies. 
  Ingredient companies should be working with experts in nutrition, physiology, and veterinary medicine, such as those at BSM Partners, to design, implement, and interpret clinical research to help substantiate claims and deliver the value that pet food brands and consumers deserve. After all, if ingredient suppliers and pet food brands don't do feeding studies with their products before they hit the market, pet parents' companions become the defacto study subjects and nobody wants that.


By Bradley Ques
Source: BSM Partners

About the Author
Dr. Bradley Quest, DVM, is the Principal Veterinarian at BSM Partners. He has practiced clinical veterinary medicine, developed and tested hundreds of pet food and health products, performs extensive animal health research, and helps navigate pet food ingredient approval for clients.

Tailored Fiber Solutions: How Functional Fibers Fit Your Process Needs
Vegetable Origin

3+ MIN

Tailored Fiber Solutions: How Functional Fibers Fit Your Process Needs

JRS provides an extensive portfolio of fiber ingredients compatible with a wide variety of manufacturing processes and formulation needs. These fibers support the development of more sustainable, health-focused pet food products that stand out in the market and promote better pet well-being.
  Consistency, texture, and uniformity are critical quality parameters in pet food products that directly affect consumer acceptance but can be challenging to control. Due to the inherent variability of raw materials and the complexities involved in manufacturing processes, achieving optimal product consistency requires precise formulation and process control. Commonly utilized binders —including spray-dried plasma, wheat gluten, and albumin— are widely employed in restructured meat products such as chunks, as well as across various meat applications. These binders are valued for their superior swelling properties, water-binding capacity, and emulsification performance, which contribute significantly to the structural integrity and textural quality of the final product.
  A series of pilot-scale trials conducted at JRS's Technical Competence Center in Rosenberg, Germany, demonstrated that partial substitution of conventional binders with a functional long cellulose fiber delivers a favorable cost-benefit outcome. Across wet pet food and other high moisture applications, replacing spray-dried plasma with cellulose fiber at a ratio of 2/1 optimizes critical process parameters during steam tunnel cooking and enhances the textural properties of chunks both before and after the retorting step. However, not only does the long fiber perform as chunk solidifier it also accelerates the cooking in the steam tunnel contributing to energy savings.
  Pet food manufacturers and entrepreneurs focus on optimizing operations and enhancing sustainability to protect and increase their revenue. Typically, every pet food and treat format offers opportunities to lower costs, boost production efficiency, and realize energy savings. In dry pet foods with high fresh meat inclusion and snacks, specialized long cellulose fibers contribute to high structural connectivity, improved texture, and minimized shrinkage after drying.
 
  In addition to these quality and processing benefits, these functional fibers support greater sustainability in production. Trials with meat-based snacks have demonstrated that incorporating long cellulose fibers can reduce drying times by up to 50% (see diagram 1), resulting in significant energy savings and relieving capacity constraints in the drying process. Together, these improvements support increased product throughput and manufacturing operations that are more efficient.
  Recently, the JRS portfolio has been expanded to include a natural plant fiber with unique fat-binding properties. Fat loss is a common challenge, particularly under high-temperature conditions such as those encountered during storage, transport, or production. These losses can compromise product quality and consistency.
  Products like licks and pastes, which often contain around 30% fat, benefit significantly from the inclusion of this fiber. It helps prevent the separation of fat and solids, thereby enhancing homogeneity.
  Similarly, snacks and treats with high meat content can experience substantial fat loss during drying. This issue is also relevant in plant-based products that include vegetable oils (e.g., sunflower oil), which have a low melting point and are prone to separation.
  In trials with beef jerky-style snacks —where fat losses of up to 20% were observed during drying— the addition of the fat-binding fiber resulted in non-detectable fat losses.
  In commercial production, this innovation can help optimize operations by increasing product yield and minimizing downtime required for cleaning.   Conclusion   Integrating specialized fibers into pet food formulations exemplifies how targeted ingredient innovations can drive advances in manufacturing efficiency, product quality, and sustainability in the evolving pet food landscape. 



By Dr. Astrid Bosse - Scientific Advisor - JRS Petfood & Aquafeed
Source: All Pet Food Magazine

Keeping the Doctor Away With Algal Omega-3s Each Day
Vegetable Origin

5+ MIN

Keeping the Doctor Away With Algal Omega-3s Each Day

Pet insurance data reveals a consistent pattern: the same health conditions appear year after year as the most common reasons pet parents file claims.1 From skin allergies and ear infections to joint problems and anxiety, these recurring issues highlight both the challenges pets and their owners face, and the opportunities for proactive nutrition to make a meaningful difference. 
  While illness throughout a pet's life may seem inevitable, emerging science suggests that targeted nutritional intervention—particularly through omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)—can play a significant role in supporting pet health and potentially reducing the frequency and severity of these common claims.2 
  For manufacturers, this presents a compelling opportunity. Formulating with clinically backed omega-3s not only delivers measurable health benefits but also addresses the specific concerns that drive pet parents to seek veterinary care most often.
  When inflammation drives the veterinary visit
A closer examination of insurance data reveals something striking: the majority of frequent claims share a common denominator—inflammatory processes. From the persistent scratching of allergic dermatitis to the joint stiffness of arthritis, inflammation underlies the discomfort that prompts millions of veterinary consultations annually.3,4
  This connection transforms omega-3 fatty acids from simple nutrients into strategic interventions. Research demonstrates that EPA and DHA supplementation significantly improved the Omega-3 Index in dogs while reducing overall pain scores.  Quality of life scores also improved, indicating that these nutrients can help tackle the underlying inflammatory cascade through their anti-inflammatory properties.6
  Addressing the needs of an aging pet population
As veterinary medicine enables pets to live longer, age-related joint deterioration has become a defining health challenge. The dramatic 49% increase in osteoarthritis claims reflects this demographic shift.2 Clinical studies show that omega-3s can help reduce the severity of symptoms associated with arthritis in pets by inhibiting the production of inflammatory compounds that contribute to joint pain and swelling.6
  Skin health is under the surface
When skin allergies consistently rank as a top insurance claim, the welfare implications are substantial.1 A systematic review of EPA and DHA supplementation found therapeutic benefits in canine allergic dermatitis, with omega-3 fatty acids helping to manage several inflammatory skin disorders through their immunomodulatory and anti-inflammatory effects.7 
  Systematic immune support
The potential of omega-3s becomes more apparent when examining their role in immune regulation. Research shows that increased circulating levels of EPA and DHA result in decreased expression of inflammatory markers.7 Additionally, they serve as precursors to potent anti-inflammatory and pro-resolving mediators, enhancing their immunomodulatory effects.7 This systemic immune support creates a foundation of resilience that may help pets better withstand typical health challenges—from recurring ear infections to stress-related conditions.
  Cognitive wellness and emotional balance
Beyond physical health, DHA's concentrated presence in neural tissue positions it as a key player in brain function and cognitive development. Studies show that DHA may improve cognitive function in older dogs, while also supporting proper brain and eye development in puppies.7 For pets experiencing anxiety, cognitive support through optimal brain nutrition offers a foundational approach to behavioral wellness. 
  This neurological resilience becomes particularly valuable as stress-related behaviors and cognitive decline represent growing concerns for pet families.
  A new paradigm: proactive nutrition for sustainable pet health
The persistence of specific pet health issues suggests an opportunity to transform pet healthcare from reactive treatment to proactive wellness. This shift toward preventive, holistic pet health also aligns with another key trend among pet parents: sustainability. Pet parents tend to be more eco-conscious than non-pet owners8 and 70% say they are actively seeking ways to reduce their environmental footprint.8 This opens up a huge opportunity for pet food manufacturers to innovate with algal omega-3s, giving pet parents integrated solutions that address individual pet wellbeing and provide planetary care.
  Unlike traditional fish-derived omega-3s, algal sources go directly to the original producers—marine microalgae—delivering superior nutritional density while protecting ocean ecosystems. dsm-firmenich's algal omega-3 solutions exemplify this approach: DHAgold™ delivers clinically-proven cognitive benefits, while Veramaris® Pets provides 60% EPA and DHA content—more than double the potency of conventional fish oils. Both ingredients enable manufacturers to create products that address the root causes of common insurance claims while satisfying growing demands for responsible sourcing.
  This convergence of proactive health management and ecological responsibility represents the future of pet nutrition. For manufacturers, algal omega-3s offer the compelling combination of clinical efficacy, consumer appeal, and environmental integrity that defines next-generation pet food formulation. In an industry where pets are family members deserving optimal care, this integrated approach delivers measurable health outcomes while supporting the sustainable practices that modern pet families expect.
  For more information about dsm-firmenich's sustainable omega-3 solutions, visit https://www.dsmfirmenich.com/en/businesses/taste-texture-health/markets-products/pets/omega-3-solutions.html 
  To get in touch, contact:
Felipe Cabanne,
Pet Food Account Manager – South America
E: Felipe.Cabanne@dsm-firmenich.com 
M: +55 16 99643-9143 
Source: DSM Firmenich 
References
1 Nationwide. "Skin allergies, gastrointestinal disease among most common conditions that prompt veterinary visits." Nationwide. September 12, 2024. [Accessed: July 2, 2025] https://news.nationwide.com/most-common-conditions-that-prompt-veterinary-visits-2024/
2 "The Effects of Omega-3 Supplementation on the Omega-3 Index and Quality of Life and Pain Scores in Dogs," PMC, accessed July 2, 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC11545626/
3 Yasutomo Imai, K. Yasuda, M. Nagai, Minori Kusakabe, M. Kubo, K. Nakanishi and K. Yamanishi. "IL-33-induced atopic dermatitis-like inflammation in mice is mediated by group 2 innate lymphoid cells in concert with basophils.." The Journal of investigative dermatology (2019). https://doi.org/10.1016/j.jid.2019.04.016.
4 Kutty Selva Nandakumar, Qinghua Fang, Isabella Wingbro Ågren and Zoe Fuwen Bejmo. "Aberrant Activation of Immune and Non-Immune Cells Contributes to Joint Inflammation and Bone Degradation in Rheumatoid Arthritis." International Journal of Molecular Sciences, 24 (2023). https://doi.org/10.3390/ijms242115883.
5 Carlisle, Carolina, Brandon T. Metzger, Nathan L. Tintle, Kristine Polley, Kristina H. Jackson, Sara Le Brun‑Blashka, Jody Griffiths, and William S. Harris. 'The Effects of Omega‑3 Supplementation on the Omega‑3 Index and Quality of Life and Pain Scores in Dogs.' Animals 14, no. 21 (October 29, 2024): 3108. doi:10.3390/ani14213108
6 Magalhães, Tomás Rodrigues, Ana Luísa Lourenço, Hugo Gregório, and Felisbina Luísa Queiroga. "Therapeutic Effect of EPA/DHA Supplementation in Neoplastic and Non-neoplastic Companion Animal Diseases: A Systematic Review." Animals 11, no. 7 (2021): 1997. doi:10.3390/ani11071997.
7 American Kennel Club. "Fish Oil for Dogs: What to Know." American Kennel Club. June 14, 2024. [Accessed: July 2, 2025] https://www.akc.org/expert-advice/nutrition/fish-oil-for-dogs/
8 Euromonitor. 'Sustainable Ingredients in Pet Care', 2022. https://www.euromonitor.com/article/sustainable-ingredients-in-pet-care  

Understanding Minimally Processed: What It Really Means for Your Pets Food
Formulation

5+ MIN

Understanding Minimally Processed: What It Really Means for Your Pets Food

Processing simply means altering an ingredient's chemistry, structure, or safety profile. It can be as gentle as hydrating a pulse or fermenting kefir, or as intensive as retort canning. In other words, each processing step exists because it solves a specific problem, such as improving digestibility, extending shelf life, controlling pathogens, enhancing palatability, preserving texture, or maintaining color, often addressing multiple issues simultaneously.  
  The real question is how much processing is happening, why, and what does it mean for nutrition and safety? 
  Regulatory Definitions 
There are currently no regulatory definitions for 'minimally or lightly processed,' 'gently cooked,' or even 'fresh' pet food established by the Association of American Feed Control Officials (AAFCO). The closest AAFCO definition pertains to the 'natural' claim, which allows for common heat or mechanical steps such as rendering, extrusion, purification, and fermentation. Even then, there is no use of the phrase 'minimally processed.'  
  However, the USDA's 'natural' claim states: 'A product containing no artificial ingredient or added color and is only minimally processed. Minimal processing means that the product was processed in a manner that does not fundamentally alter the product.' But there is no numerical cap for 'minimal.' The Food, Drug, and Cosmetic Act, established by the Food and Drug Administration (FDA), does not define 'minimally processed' either, and no temperature limits are specified.  
  Photo by Nadtochii   Enter NOVA System—Helpful Lens or Marketing Hammer? 
In 2009, nutrition scientists at the University of São Paula proposed the NOVA classification system. This four-tiered system ranks foods by the extent and purpose of industrial processing. The tiers are as follows: 
  Group 1: Unprocessed/Minimally Processed—Edible parts of plants, animals, fungi, algae, or water used almost as found in nature, or altered only by basic preservation steps (washing, peeling, drying, chilling, freezing, pasteurizing, fermenting, etc.) 
  Group 2: Processed Culinary Ingredients—Substances extracted from Group 1 foods or nature (oils, butter, lard, sugar, honey, salt) via pressing, milling, refining, evaporating, or drying. 
  Group 3: Processed Foods—Group 1 foods modified by adding Group 2 ingredients (salt, oil, sugar) and/or by preservation or non-alcoholic fermentation; usually have 2–3 ingredients and remain recognizable as the original food. 
  Group 4: Ultra-Processed Foods—Industrial formulations made mostly or entirely from refined food fractions (starches, sugars, oils, proteins) plus additives that create colors, flavors, textures, or extend shelf-life; contain little if any intact whole food.  
  The model was never intended to regulate pet food; yet, the term 'ultra-processed' has been eagerly adopted by bloggers and marketers to cast conventional kibble as nutritionally suspect. The trouble is that NOVA's criteria focus on how a product is assembled, rather than whether it meets nutrient profiles, safety standards, or digestibility targets.  
  Here's the bottom line: NOVA does provide a consumer-friendly shorthand for human diets, but it isn't recognized by the FDA, USDA, or AAFCO, and can be misleading when pasted onto pet nutrition. So, when you see 'ultra-processed' used to dismiss a pet food, first ask: 'What nutrient, safety, or digestibility metric is actually falling short? Or is this just another buzzword trying to 'make fetch happen?'' 
  Is 'Minimally/Lightly Processed' Automatically Better? 
Again, it depends on the product's ultimate goal. Is it always better? No, not always. Less heat means fewer automatic kill steps for pathogen safety. In these cases, it is prudent to add a kill step. High-pressure processing (HPP) or steam pressurized pasteurization (SPP) are two methods that can be used to reduce microbial load. The major difference between the two is that HPP is technically a non-thermal process, while SPP relies on heat to inactivate microbes.     Certain ingredients, such as beans or potatoes, require processing to reduce anti-nutrient factors and enhance the digestibility of their starches. Without the appropriate process, there is an increased chance of your pet consuming an ingredient that is not healthy for them. On the other hand, ingredients that are not exposed to high levels of heat often have higher nutrient retention, albeit at the cost of increased retention of anti-nutrient factors.  
  Even the gentlest recipe requires a validated kill step. Whether a brand relies on HPP, SPP, or heat in extrusion or retort, the goal is the same: to achieve at least a 5-log reduction of pathogens such as Salmonella and Listeria without overcooking nutrients. 
  Bottom line, the degree of processing should not be on the product as a whole, but on the individual ingredients and what is appropriate from a safety and nutritional perspective.  
  Looking Ahead: How the PURR Act Could Bring Clarity 
The Pet Food Uniform Regulatory Reform (PURR) Act of 2025, now pending before the House of Representatives, proposes a single federal standard for labeling dog and cat food. If passed, it offers a viable vehicle to define descriptors like lightly cooked, air-dried, and freeze-dried raw in measurable terms—think core temperature limits, required pathogen-reduction methods, and even minimum digestibility disclosures.   
  However, the proposed bill is not without its flaws, which BSM Partners has addressed in articles, 'Time for change: Addressing regulatory reform in pet food,' and, 'AAFCO: PURR Act Places Pet Food Transparency on the Chopping Block,' as well as in an episode of the Barking Mad podcast, 'Barking Up the Wrong Tree: How the PURR Act Could Undermine Pet Food Transparency and Safety'.  
  By checking the Federal Register and Regulations.gov, you can keep up to date on any scheduled public hearings or if there is an open comment period for the PURR Act. By participating in this process, brands can help ensure that "minimal processing" becomes a transparent promise backed by science, not just clever marketing copy. 
  Whether you're perfecting your recipe, validating a kill step, or trying to understand where your next opportunity is in the industry, our experts at BSM Partners specialize in audits that keep nutrition, safety, and regulatory compliance in balance, understand market trends, and formulate a nutritious formula for your desired format.  
  About the Author
Dr. Sydney McCauley is a Board-Certified Companion Animal Nutritionist and earned both her bachelor's and doctoral degrees at Virginia Tech in Animal and Poultry Sciences. McCauley's research was in nutritional physiology with a focus on understanding the effects of low birth weight on glucose, fatty acid, carbohydrate, and amino acid metabolism in skeletal muscle and overall metabolic homeostasis during neonatal development.


By Sydney McCauley
Source: BSM Partners

Pet Supplements: When Science, Cost, and Chews Collide
Formulation

6+ MIN

Pet Supplements: When Science, Cost, and Chews Collide

During those 11 years, I evaluated hundreds, possibly thousands, of products. Over and over, I saw the same issues: questionable scientific support, underdosed active ingredients, and formulations that just didn't deliver. As a veterinarian and consumer, it was perplexing. I remember thinking, 'How hard can it be to make a supplement that works?' You just find ingredients with solid science behind them, combine them into a formula, and voilà, a great supplement, right?  
  Then I joined BSM Partners and had the opportunity to develop my first veterinarian-formulated supplement. I was thrilled! This was the chance I had been waiting for—a chance to do it right. However, what became abundantly clear was that the roadblocks I had previously attributed to poor product development were not just isolated cases or evidence of carelessness. They were symptoms of deeper, industry-wide challenges that even the most seasoned professionals must navigate with care. 
  Step 1: Scientifically Backed Ingredients  
Finding ingredients with strong, species-specific scientific support for safety and efficacy is the foundation for an efficacious product. Surprisingly, sometimes studies supporting the use of functional ingredients specifically for dogs and cats are scarce. While there is plenty of data from rodents and humans, the companion animal section is sparse. Then, when it's narrowed down to studies that include safety data or effective doses, the list shrinks dramatically for dogs and is almost nonexistent for cats.  
  This is an industry-wide limitation that product developers must contend with across the board. Does that mean a supplement is ineffective if there is no supporting data? Not necessarily. Formulators may often extrapolate from other species or use synergistic combinations at sub-efficacious levels. But when that approach is taken, validating the finished product through clinical testing is key, but that's where the industry often stumbles. Testing finished products for efficacy is arguably the most critical step in supplement development, and it is often skipped because it can be expensive, time-consuming, and a strain on resources. However, if you're not testing your product before it goes to market, you're essentially using customers' pets as test subjects. 
  Step 2: Making It Fit 
Next is formulation. An ingredient with solid scientific backing still has to 'fit' within a chew or powder scoop, and that's where another layer of difficulty emerges. Many efficacious ingredients' research shows results at high inclusion rates —doses that simply don't fit in a chew or daily serving. For example, take fructooligosaccharides (FOS), which support digestive health, but the dose that actually works in dogs is far more than can be realistically delivered in a small, palatable chew.  
  Then there are cats —if finding data for dogs is hard, cat research is like finding water in the Sahara desert. When formulating for cats, the problem compounds: limited data, stricter palatability demands, and dosing constraints make feline supplements one of the most complex categories in the market. These are not niche concerns; they are fundamental limitations that affect nearly every company trying to build a meaningful product. 
  Step 3: Cost vs. Efficacy 
Once a feasible ingredient is identified, it's time to calculate the cost. Here's the kicker: the best-supported ingredients—for example, postbiotics with species-specific clinical trials—can cost hundreds of dollars per kilogram. Delivering a daily dose at the study-supported level could cost the consumer $15 to $20 per day, which may not be economically viable for pet parents – especially in today's world. Companies face this dilemma: how to balance scientific rigor with cost-accessibility. It's a strategic, not just scientific, decision, and one that profoundly shapes the final product.    Step 4: Will It Even Work in Manufacturing? 
Now, the ingredients that are efficacious, cost-effective enough, and fit into a chew or scoop have been identified. The next question: can it be manufactured? Sometimes, a last-minute consideration, but food science and formulation engineering are critical to the process. Some ingredients are incompatible or can be rendered ineffective with certain processing methods.    Step 5: The Marketing Reality Check 
Next, customer perception is layered into the equation. For example, a novel ingredient with supporting evidence for efficacy has been identified. Is it familiar with pet parents? Do pet parents understand the connection between the ingredients and the functionality? Formulators must balance new, innovative active ingredients with those consumers know and love.     Step 6: Palatability Hurdle 
The steps have been taken to create an effective supplement with evidence supporting claims, and consumer perception considered, it is time to tackle palatability. Creating a tasty product is where the rubber meets the road. If this supplement is perfect on paper, but if pets won't eat it, it might as well not exist.  
  Palatability isn't just a finishing touch; it's a gatekeeper. Texture, aroma, flavor profiles, and even how the product breaks apart in the mouth —all these things matter, especially for cats, who can be notoriously picky. A core formulation challenge faced by every brand is making something taste good to a dog or cat while preserving the stability of active ingredients; it is a whole science of its own! 
  For personal experience, when I finally finished formulating my first supplement, I felt like celebrating. Real-world experience taught me that reviewing supplements versus creating them is two separate beasts. Creating a supplement that delivers and that pets will willingly consume is harder—yet can be even more rewarding—than I ever imagined. 
  Step 7: Clinical Efficacy Testing 
Here's the piece most often missing: does the final product actually work, and is it safe? Not the individual ingredients in isolation, but the fully formulated product in the chosen format (like a chew or powder). That's where clinical efficacy and safety testing come into the picture. This step validates whether the supplement delivers meaningful benefits in pets and whether the formulation is safe. It also helps uncover synergistic effects or limitations that cannot be predicted on paper. Unfortunately, few companies invest in this step, despite it being critical for establishing credibility and long-term success. At BSM Partners, we emphasize this phase because it closes the loop between formulation and function, allowing pet owners to truly trust that what they are purchasing is effective and safe. 
  So, How Do You Make a Good Supplement? 
What I learned during this project at BSM Partners is that building a supplement that is safe, effective, manufacturable, and palatable is not simply a matter of good intentions or veterinary knowledge. It's an exercise in navigating a complex landscape of real-world tradeoffs that impact every brand in this space. These aren't just personal lessons; they are industry-wide realities that demand technical fluency, strategic restraint, and scientific integrity. That's what makes this work both challenging and deeply rewarding. 
  At BSM Partners, we bring all these elements together under one roof. Whether building a new supplement brand or refining an existing product line, we can help strike the balance between scientific integrity, practical formulation, and consumer appeal. It's not easy, but when done right, it's worth it. 
  About the Author
Dr. Katy Miller works as the Director of Veterinary Services at BSM Partners. She earned her veterinary degree at Ross University and completed her clinical year at Louisiana State University. She previously served for 11 years as the Director of Dog and Cat Health and Nutrition for Mud Bay where she earned multiple certifications and specialized in pet food nutriton, prior to which she practiced general and emergency medicine for seven years. She is also a competitive three-day eventer, licensed falconer, and claims only two (Golden and Mini Doxie) of their nine dogs.


By Katy Miller
Source: BSM Partners


Formulation

Formulation <em>Gleditsia Amorphoides</em> as a Source of Saponins and Bioactive Compound for Pet Food

6+ MIN

Gleditsia Amorphoides as a Source of Saponins and Bioactive Compound for Pet Food

Gleditsia amorphoides   In recent years, new plant-based sources of saponins have been investigated to expand the functional benefits of these compounds, with Gleditsia amorphoides emerging as a promising alternative. This tree species, belonging to the Fabaceae family, is native to temperate and subtropical regions and has traditionally been used for timber and industrial purposes. Gleditsia amorphoides presents a high saponin content (approximately 22%, compared to 7–15% in Yucca schidigera) and a relevant profile of bioactive compounds, including galactomannans and polyphenols (Perduca et al., 2013; Lu et al., 2024).

Although studies are still limited, initial evidence—mainly from in vitro experiments—suggests that gleditsia extract can modulate the intestinal microbiota by promoting saccharolytic bacteria, reducing microorganisms associated with proteolytic fermentation, and increasing the production of metabolites with antioxidant and anti-inflammatory potential (Francis et al., 2002; Sparg et al., 2004; Sittikijyothin et al., 2005). To further investigate this potential, a study was conducted in adult dogs to evaluate the effects of dietary supplementation with Gleditsia amorphoides and Yucca schidigera extracts on intestinal fermentation, fecal metabolites, and systemic biomarkers related to inflammation and antioxidant status.   Gleditsia amorphoides
Source: Wikimedia Commons   Study on Gleditsia amorphoides in Dogs
Materials and Methods The study was carried out at the canine nutrition laboratory (LENUCAN) at the Federal University of Parana (UFPR) in Brazil and was approved by the institution's Animal Ethics Committee (protocol no. 013/2024). Eighteen healthy adult beagle dogs (10 males and 8 females), approximately two years old and with an average body weight of 12.2 ± 1.33 kg, were randomly assigned to three experimental groups (six dogs per group): control (unsupplemented diet), diet supplemented with 200 g/ton of Yucca schidigera extract, and diet supplemented with 200 g/ton of Gleditsia amorphoides extract (Sapcor®, Bioaromas do Brasil)  Diets differed only in the inclusion of the additives. Dogs were fed experimental diets twice daily for 20 days.

At the end of the experimental period, fresh fecal samples were collected to evaluate fecal characteristics and metabolites associated with intestinal fermentation. Fasting blood samples were also collected to assess systemic physiological responses to dietary treatments. Data were analyzed using analysis of variance (ANOVA), followed by Tukey's test when significant differences were identified. Non-parametric data were evaluated using the Kruskal–Wallis test, considering statistical significance at p < 0.05.
Results
No adverse reactions to feeding—such as vomiting, diarrhea, or feed refusal—were observed during the experimental period, indicating good acceptance.
Intestinal Fermentation Metabolites
Dietary supplementation with Gleditsia and Yucca influenced several metabolites associated with intestinal fermentation (Table 1). Dogs fed diets containing Yucca schidigera or Gleditsia amorphoides showed lower fecal ammonia concentrations compared to the control group (P < 0.05), suggesting reduced proteolytic fermentation in the gut. However, only dogs supplemented with Gleditsia showed: more fecal concentrations of propionate, higher total short-chain fatty acids (SCFA), and lower concentrations of 4-methylvalerate compared to the Yucca group (P < 0.05).

Propionate is a characteristic metabolite of saccharolytic fermentation and has been associated with potential anti-inflammatory effects in the gastrointestinal system, including inhibition of the Toll-like receptor 4 accessory protein CD14. This results in reduced activation of NF-κB-mediated inflammatory pathways and decreased production of pro-inflammatory cytokines (Hoyles et al., 2018).
  Table 1 – Mean fecal concentrations (dry matter basis) of ammonia, short-chain fatty acids (SCFA), and branched-chain fatty acids (BCFA) in dogs from Control, Gleditsia, and Yucca groups.
  Note: SEM: Standard error of the mean. P: Probability.
a,b Different letters indicate statistical difference according to the Tukey test (P < 0.05).
  Additionally, fecal concentrations of histamine and spermidine were lower in the Gleditsia group compared to the control group (P < 0.05, Figure 1). These compounds are derived from microbial amino acid degradation and are associated with proteolytic fermentation, which may exert harmful effects on intestinal mucosa and liver function when present at high concentrations (Brito et al., 2010; Souza et al., 2025).   a,b Different letters indicate statistical difference according to the Tukey test (P < 0.05).
Figure 1: Fecal concentrations (dry matter basis) of biogenic amines in dogs from Control, Gleditsia, and Yucca groups.
These effects may be related to the composition of Gleditsia extract, which combines triterpenoid saponins with galactomannans that may exert prebiotic activity (Lu et al., 2024). This combination may promote a shift in microbial fermentation patterns—from predominantly proteolytic to more saccharolytic pathways—as also suggested by in vitro studies using human fecal microbiota exposed to Gleditsia extracts (Wang et al., 2023). Furthermore, saponins may contribute to the reduction of proteolytic metabolites through different mechanisms, including inhibition of bacterial urease activity, direct binding to nitrogenous compounds, and modulation of the intestinal microbiota (Dos Reis et al., 2016; Zhang et al., 2023).
Systemic Biomarkers
Dogs receiving diets supplemented with Gleditsia amorphoides or Yucca schidigera showed: lower lipid peroxidation (LPO) and higher catalase (CAT) activity compared to the control group (P < 0.05, Figure 2), indicating improved antioxidant status. Additionally, dogs in the Gleditsia group showed lower alkaline phosphatase activity compared to the control group (Control: 45.10 U/L; Gleditsia: 33.30 U/L; P < 0.05). These systemic effects may be partially associated with reduced production and absorption of proteolytic metabolites in the intestine, which can trigger inflammatory and oxidative responses (Souza et al., 2025). Additional antioxidant effects may also be linked to polyphenolic compounds present in Gleditsia, such as quercetin derivatives, which have been shown to activate the Nrf2 oxidative stress response pathway in canine hepatocyte cultures (Lu et al., 2024).     a,b Different letters indicate statistical difference according to the Tukey test (P < 0.05).
Figure 2: Lipid peroxidation (LPO, mmol/mL) and catalasa (CAT, mU/mL) in dogs from Control, Gleditsia, and Yucca groups.
Overall, these findings suggest that dietary supplementation with Gleditsia amorphoides may contribute to improving intestinal fermentation patterns and antioxidant status in dogs, indicating potential functional benefits for canine nutrition.
Conclusion
The study conducted at UFPR indicates that dietary supplementation with Gleditsia amorphoides beneficially modulates intestinal fermentation metabolites in dogs. These changes were accompanied by improvements in systemic antioxidant markers, including reduced lipid peroxidation and increased catalase activity. Overall, these findings suggest that botanical additives containing saponins and associated bioactive compounds may contribute to intestinal functionality and systemic health in dogs. By Vanessa R. Olszewski, Danieli Z. Cypriano and Ananda P. Félix – BioAromas
Source: All Pet Food Magazine
  References
Brito, C., Félix, A., Jesus, R., França, M., Oliveira, S., Krabbe, E., & Maiorka, A. (2010). Digestibility and palatability of dog foods containing different moisture levels, and the inclusion of a mould inhibitor. Animal Feed Science and Technology, 159, 150–155. https://doi.org/10.1016/j.anifeedsci.2010.06.001 
Dos Reis, J. S., Zangerônimo, M. G., Ogoshi, R. C. S., França, J., Costa, A. C., Almeida, T. N., Dos Santos, J. P. F., Pires, C. P., Chizzotti, A. F., Leite, C. A. L., Saad, F. M. O. B. (2016). Inclusion of Yucca schidigera extract in diets with different protein levels for dogs. Animal Science Journal. 87: 1019–1027. https://doi.org/10.1111/asj.12535. 
Francis, G.; Kerem, Z.; Makkar, H. P. S.; Becker, K. The biological action of saponins in animal systems: a review. British Journal of Nutrition, Cambridge, v. 88, n. 6, p. 587–605, 2002. DOI: https://doi.org/10.1079/BJN2002725.
Hoyles, L., Snelling, T., Umlai, U. K., Nicholson, J. K., Carding, S. R., Glen, R. C., McArthur, S. (2018). Microbiome–host systems interactions: protective effects of propionate upon the blood–brain barrier. Microbiome. 6, 55. https://doi.org/10.1186/s40168-018-0439-y. 
Lu, G., Ren, T., Zhao, Z., Li, B., & Tan, S. (2024). Chemical component differences in the endosperm of Gleditsia species seeds revealed based on comparative metabolomics. Food Chemistry: X, 21, 101060. https://doi.org/10.1016/j.fochx.2023.101060. 
National Research Council (NRC). (2006). Nutrient requirements of dogs and cats. National Academies Press.
Perduca, M. J. et al. Gleditsia amorphoides galactomannans: physicochemical properties and industrial applications. In: RAMAWAT, K. G.; MÉRILLON, J. M. (eds.). Polysaccharides: bioactivity and biotechnology. Cham: Springer International Publishing, 2013.  DOI: 10.1007/978-3-319-03751-6_39-1.
Sittikijyothin, W.; Torres, D.; Gonçalves, M. P. Modelling the rheological behaviour of galactomannan aqueous solutions. Carbohydrate Polymers, Oxford, v. 59, n. 3, p. 339–350, 2005. DOI: https://doi.org/10.1016/j.carbpol.2004.10.005.
Sparg, S. G.; Light, M. E.; Staden, J. Biological activities and distribution of plant saponins. Journal of Ethnopharmacology, Amsterdam, v. 94, n. 2-3, p. 219–243, 2004. DOI: https://doi.org/10.1016/j.jep.2004.05.016.
Souza, R. B. M. S., Fernandes, E. L., Santos, L. N. A., Lima, L. S., Silva, H. L., Putarov, T. C., Oliveira, S. G., Felix, A. P. (2025). Effects of yeast beta-1,3/1,6-glucans on nutrient digestibility, intestinal functionality, and immune and antioxidant variables in growing dogs submitted to spay or neutering surgery. Plos One. 20(9): e0331843. https://doi.org/10.1371/journal.pone.0331843. 
Wang, H., Lai, C., Tao, Y., Zhou, M., Tang, R., Yong, Q. (2023). Evaluation of the enzymatic production and prebiotic activity of galactomannan oligosaccharides derived from Gleditsia microphylla. Fermentation. 9(7), 632. https://doi.org/10.3390/fermentation9070632. 
Zhang, Y., Wang, L., Chen, X., Liu, Y., & Li, J. (2023). Quillaja saponaria extract modulates gut microbiota and reduces proteolytic bacteria in dogs: A dose-response study. Veterinary Microbiology, 276, 109634. https://doi.org/10.1016/j.vetmic.2023.109634. 

Formulation Holistic Stability with Functional Ingredients and Real Value

5+ MIN

Holistic Stability with Functional Ingredients and Real Value

3A BIOTECH and Real Value: You Don't Buy It, You Protect It
The value of a raw material is not defined only by its specification sheet, but by its ability to remain stable over time. Pet food is a living system, exposed to chemical changes, sensory alterations and microbiological hazards during processing, storage and transport—and finally when the pack is opened at home. Throughout that journey, stability determines whether the formulation delivers on its promise.

How to Prevent Loss of Real Value    
Fats and oils, meals and proteins are core pillars of metabolisable energy, palatability and the supply of essential nutrients. At the same time, they are the components most vulnerable to degradation. Lipid oxidation generates free radicals and peroxides that damage vitamins and other fat-soluble compounds, alter aroma and reduce the food's actual bioavailability. These processes begin as soon as the raw material is exposed to air and continue throughout the entire shelf life.

The consequences are direct: a drop in real energy delivery, loss of palatability, the formation of undesirable secondary compounds and reduced aroma stability. In practice, the lipid profile the animal consumes may no longer match what is declared. That is why oxidative stability is a central parameter of real value: if an ingredient oxidises easily, its nutritional and functional value diminishes long before it reaches the consumer.

Moreover, oxidation is not only a sensory issue. Certain compounds derived from rancidity can contribute to digestive imbalances. In pet food—where tolerance and the microbiome matter—protecting against oxidation also protects the nutritional experience.
3A BIOTECH and Microbiological Safety: The Other Pillar of Real Value
Alongside oxidative loss comes microbiological instability. Animal-origin raw materials and certain cereals can promote the growth of moulds and bacteria if not properly controlled. The challenge is compounded by the potential presence of heat-stable mycotoxins, which can survive processing and compromise final product safety.

Even moderate microbial loads can accelerate degradation and shorten shelf life in ways that are not immediately visible. For that reason, microbiological quality is a critical component of real value: it determines safety, stability and formulation performance, and it also influences batch-to-batch consistency.

Beyond Price: Technological Efficiency and Functional Value 
In a market that has historically competed in cost, more and more manufacturers recognise that differentiation is not only about purchase price, but about true functional value: what an ingredient delivers, what it preserves, and what it guarantees. Evaluation moves beyond '€/tonne' and starts to include stability, digestibility, control of wastage, sensory consistency and fewer issues/complaints.

This evolution reflects a more demanding end consumer seeking premium, natural products with tangible benefits. It also pushes the industry towards integrated systems that not only protect raw materials but also provide technological and biological functionality.
3A BIOTECH Functional Ingredients: Protect, Complement, Optimise
A functional ingredient—typically natural in origin, derived from plants, microorganisms or bioactive extracts—provides additional benefits either to the organism or to the formulation itself. In pet food, this translates into improvements, such as gut-health support, immune reinforcement, oxidative stabilisation, microbiota modulation, cellular protection against oxidative stress, and improved digestibility.

From a technological perspective, functional ingredients extend product stability, preserve organoleptic integrity and reduce degradation during storage. They can also help optimise texture, stabilise emulsions, minimise unwanted reactions and support preservation, by reducing variability and enabling more consistent nutritional claims.
Holistic Stability with 3A BIOTECH: Antioxidants + Preservatives, By Design
To preserve real value, the industry relies on carefully designed antioxidant and preservative systems. Antioxidants work by preventing free-radical formation and protecting lipid integrity. In parallel, preservatives based on organic acids help keep microbial loads under control, avoiding deterioration that would reduce the initial nutritional value.

When these systems are formulated with an integrated approach—synergy, correct dosing and process compatibility—they stop being 'additives' and become functional ingredients: they influence stability, safety and overall formula performance.
3A BIOTECH in Dry and Wet: Two Challenges, One Goal
In dry foods, the risk of rancidity increases when oxidation-susceptible meals are combined with oils applied as coatings. Processing and storage time can intensify degradation, affecting aroma, flavour and acceptance by the animal.

In wet foods, although wax coatings can help minimise drying out—particularly relevant for cats due to their more fragmented feeding pattern—it remains essential to stabilise emulsions and control oxidative and microbiological degradation. Here, emulsion physical stability is key to maintaining texture, appearance and palatability: small variations can trigger defects visible to the consumer.
3A BIOTECH TOCOTYROSOL: Stability + Functionality in One Solution
A balanced combination of antioxidant protection and functional support is found in formulations such as TOCOTYROSOL by 3A BIOTECH. This solution is developed using natural antioxidants—tocopherols and extracts of rosemary, olive and green tea—and is designed to integrate efficiently into manufacturing processes for both dry and wet foods.

Its antioxidant synergy helps preserve sensory and nutritional stability from production through to consumption, supporting lipid profile integrity, palatability and product consistency. In addition, it incorporates a prebiotic angle that supports the intestinal microbiota and digestive efficiency, aligning with the growing demand for more functional formulations.

From the manufacturer's perspective, these solutions deliver value at the technological stage (oxidation control, stability, preservation and reduced variability) and help sustain formulation performance over time. In other words, they enable the final product to fulfil the brand promise—batch after batch.
Conclusion: Raw Material, Real Value
The pet food industry no longer competes to be the cheapest, but to be the most efficient, stable and functional. In a sector where every ingredient is an investment, ensuring raw materials retain their real value is a strategic decision: it improves final quality, reduces issues and strengthens consumer trust.

At 3A BIOTECH, we help brands protect that value with natural solutions based on functional ingredients and holistic stability systems. 

Would you like to validate it on your own line? Request a technical assessment or a pilot trial with TOCOTYROSOL and see how well-designed protection can translate into greater stability, a better consumption experience and a more consistent product. By 3A BIOTECH
Source: All Pet Food Magazine


Vegetable Origin

Vegetable Origin From Alga to Bowl: Astaxanthin Supports Pet Health 

5+ MIN

From Alga to Bowl: Astaxanthin Supports Pet Health 

Owing to the ongoing anthropomorphism of pets, owners are taking a closer look at what they're feeding their beloved companions. Just as they themselves are opting for healthier and cleaner-label nutrition—and starting to consider the associated environmental aspects—, owners want to ensure that the same standards apply to their pet's meals. This is manifesting as a shift towards providing fresh food or preferentially selecting more natural or organic pet food products.

Overall, the pet food sector is witnessing continuous growth. The market size in Europe is estimated to be worth $55 billion in 2024 and is expected to reach a value of more than $78 billion by 2029 (growing at a CAGR of approximately 7%).1 Next to classic feed compounds, such as grain or meat, novel functional ingredients are gaining traction in this developing market. Many of these components can be both integrated into feed grades as well as pet-friendly nutraceuticals. One example is carotenoids, which are not only known for their vibrant yellow, orange, or red colours, but also for their antioxidant attributes. One carotenoid with a particularly high antioxidant power—110 times more than vitamin E—is astaxanthin. 

In nature, the most abundant source of astaxanthin is a tiny microalga called Haematococcus pluvialis. Although astaxanthin has a long history as an ingredient in human supplements, its beneficial effects were first discovered in the marine world regarding the survival and reproduction rates of salmon. Research on astaxanthin in aquaculture was also the basis for the Swedish company, AstaReal's business. The organisation was the first to produce natural astaxanthin on an industrial level and, as the subject of more than 70 clinical studies on humans and animals, it owns today's most researched astaxanthin brand in the market.
Species-Specific Research
'We wanted to understand what this might mean for different kinds of animals, so we started using the ingredient in trials with cats and dogs,' says Peter Ahlm, Head of Marketing & Sales at AstaReal. Distinct research on targeted animals is indispensable when it comes to developing a safe and efficacious product; effects might vary between species, and it's imperative to optimise the amount of ingredients to be dispensed.

There is a growing body of evidence for various positive effects of natural astaxanthin on pets' health, many of which show a similar pattern to humans. For instance, astaxanthin can support canine mobility, endurance, and muscle recovery; the cardiovascular system; cognitive function; attentiveness and at the cellular level, the mitochondria.2–5 Moreover, natural astaxanthin supplementation in dogs and cats could enhance their innate defence systems and improve both their cell-mediated and humoral immune responses.6,7 Astaxanthin also has shown potential to improve impaired vision due to age-related conditions like cloudy lenses in dogs.8 

'The recorded health effects may seem quite diverse; however, they are all rooted in astaxanthin's unique molecular structure. Due to its linear, polar-nonpolar-polar molecular layout, natural astaxanthin can effectively penetrate and traverse the cell and mitochondria membranes and neutralize reactive oxygen species (ROS) in both the hydrophobic interior and hydrophilic exterior boundaries. In addition to providing better protection to the cells and their powerhouses against oxidative stress, natural astaxanthin also has anti-inflammatory effects that support multiple bodily organs and systems.' -  Behnaz Shakersain, Scientific Affairs Manager at AstaReal.
Scoring with Natural Astaxanthin Options
As neither humans nor animals can produce astaxanthin in their bodies, they can only benefit from its protective functions through nutritional intake. To obtain effective amounts, dogs are generally recommended to be fed 1 mg of astaxanthin per 10 kg body weight, which equates to about two wild King salmon fillets for a beagle or three for a golden retriever per day. Feed or treats rich in astaxanthin might offer an easier and more sustainable solution in many cases. 

Natural algae-derived versions of astaxanthin offer additional advantages, such as higher levels of antioxidant potency. Moreover, algae play an essential role in the planet's ecosystem, and being recognised as a renewable resource resonates strongly with responsible consumers. If algae are cultivated indoors, they can be better protected from environmental harm or contamination, and the yield of astaxanthin-rich algal biomass has a higher quality profile. 

Developing a formula with healthy ingredients is only the first step, according to Peter Ahlm: 'Pet food manufacturers also need to make sure that their product will remain stable and nutritious throughout its intended shelf-life. Bioactive substances are particularly prone to interact with other compounds in multi-ingredient formulations or can degrade during harsh production processes, such as extrusion or pelleting.' 

To minimize such risks and protect the power of astaxanthin, AstaReal uses encapsulation in its animal nutrition brand NOVASTA®. Its recently launched NOVASTA® EB15 can be mixed into pet food or added to supplements and consists of algal flour (32%) encapsulated in rapeseed oil with a final astaxanthin concentration of 1.5%. Due to encapsulation, it can be better incorporated into challenging formulations, such as pellets, meal mixes, and soft chews, which are more likely to be exposed to air at ambient temperature.

If manufacturers are sensitive to the shifting demands of pet parents and are willing to combine health with sustainability trends, they are well set. Algal astaxanthin can play an assisting role in these efforts. Thanks to its antioxidant and multifunctional effects, it naturally supports the well-being of our four-legged friends while stemming from a futureproof source.
Futureproof Feeding
One of today's major challenges is how to feed the planet sustainably. In search of plant-based sources for both human and animals, algae are gaining attention. Algae are relatively easy to cultivate, are nutritious, and being considered as more sustainable than several conventional crops. One precious and health-promoting ingredient that algae offer is astaxanthin. AstaReal derives the carotenoid from the micoralgae Haematococcus pluvialis that are being cultivated indoor in specially designed photobioreactors. The company applies a unique system to reuse the excess heat produced during the algae cultivation process to heat up 2500 apartments in the nearby residential area, aiming to continuously reduce their carbon footprint.   By AstaReal
Source: All Pet Food Magazine
References
1.    Mordor Intelligence. 'Europe Pet Food Market SIZE & SHARE ANALYSIS - GROWTH TRENDS & FORECASTS UP TO 2029.' https://www.mordorintelligence.com/industry-reports/pet-food-market-in-europe-industry. Accessed Feb. 23, 2024.
2.    B.M. Zanghi, et al., 'Effects of Postexercise Feeding of a Supplemental Carbohydrate and Protein Bar with or without Astaxanthin from Haematococcus pluvialis to Exercise-Conditioned Dogs,' Am. J. Vet. Res. 76(4), 338–350 (2015).
3.    T. Murai, et al., 'Effects of Astaxanthin Supplementation in Healthy and Obese Dogs,' Veterinary Medicine: Research and Reports 10, 29–35 (2019).
4.    National Center for Biotechnology Information. 'PubChem Patent Summary for US-9820497-B2, Astaxanthin-containing pet foods.' https://pubchem.ncbi.nlm.nih.gov/patent/US-9820497-B2. Accessed Feb. 23, 2024.
5.    J.S. Park, et al., 'Astaxanthin Modulates Age-Associated Mitochondrial Dysfunction in Healthy Dogs,' Journal of Animal Science 91(1), 268–275 (2013).
6.    B.P. Chew, et al., 'Dietary Astaxanthin Enhances Immune Response in Dogs,' Veterinary Immunology and Immunopathology 140(3–4), 199–206 (2011).
7.    J.S. Park, et al., 'Astaxanthin Stimulates Cell-Mediated and Humoral Immune Responses in Cats,' Veterinary Immunology and Immunopathology 144, 455–461 (2011).
8.    W. Wang, et al., 'Antioxidant Supplementation Increases Retinal Responses and Decreases Refractive Error Changes in Dogs,' Journal of Nutritional Science 5, E18 (2016).

Vegetable Origin Tailored Fiber Solutions: How Functional Fibers Fit Your Process Needs

3+ MIN

Tailored Fiber Solutions: How Functional Fibers Fit Your Process Needs

JRS provides an extensive portfolio of fiber ingredients compatible with a wide variety of manufacturing processes and formulation needs. These fibers support the development of more sustainable, health-focused pet food products that stand out in the market and promote better pet well-being.
  Consistency, texture, and uniformity are critical quality parameters in pet food products that directly affect consumer acceptance but can be challenging to control. Due to the inherent variability of raw materials and the complexities involved in manufacturing processes, achieving optimal product consistency requires precise formulation and process control. Commonly utilized binders —including spray-dried plasma, wheat gluten, and albumin— are widely employed in restructured meat products such as chunks, as well as across various meat applications. These binders are valued for their superior swelling properties, water-binding capacity, and emulsification performance, which contribute significantly to the structural integrity and textural quality of the final product.
  A series of pilot-scale trials conducted at JRS's Technical Competence Center in Rosenberg, Germany, demonstrated that partial substitution of conventional binders with a functional long cellulose fiber delivers a favorable cost-benefit outcome. Across wet pet food and other high moisture applications, replacing spray-dried plasma with cellulose fiber at a ratio of 2/1 optimizes critical process parameters during steam tunnel cooking and enhances the textural properties of chunks both before and after the retorting step. However, not only does the long fiber perform as chunk solidifier it also accelerates the cooking in the steam tunnel contributing to energy savings.
  Pet food manufacturers and entrepreneurs focus on optimizing operations and enhancing sustainability to protect and increase their revenue. Typically, every pet food and treat format offers opportunities to lower costs, boost production efficiency, and realize energy savings. In dry pet foods with high fresh meat inclusion and snacks, specialized long cellulose fibers contribute to high structural connectivity, improved texture, and minimized shrinkage after drying.
 
  In addition to these quality and processing benefits, these functional fibers support greater sustainability in production. Trials with meat-based snacks have demonstrated that incorporating long cellulose fibers can reduce drying times by up to 50% (see diagram 1), resulting in significant energy savings and relieving capacity constraints in the drying process. Together, these improvements support increased product throughput and manufacturing operations that are more efficient.
  Recently, the JRS portfolio has been expanded to include a natural plant fiber with unique fat-binding properties. Fat loss is a common challenge, particularly under high-temperature conditions such as those encountered during storage, transport, or production. These losses can compromise product quality and consistency.
  Products like licks and pastes, which often contain around 30% fat, benefit significantly from the inclusion of this fiber. It helps prevent the separation of fat and solids, thereby enhancing homogeneity.
  Similarly, snacks and treats with high meat content can experience substantial fat loss during drying. This issue is also relevant in plant-based products that include vegetable oils (e.g., sunflower oil), which have a low melting point and are prone to separation.
  In trials with beef jerky-style snacks —where fat losses of up to 20% were observed during drying— the addition of the fat-binding fiber resulted in non-detectable fat losses.
  In commercial production, this innovation can help optimize operations by increasing product yield and minimizing downtime required for cleaning.   Conclusion   Integrating specialized fibers into pet food formulations exemplifies how targeted ingredient innovations can drive advances in manufacturing efficiency, product quality, and sustainability in the evolving pet food landscape. 



By Dr. Astrid Bosse - Scientific Advisor - JRS Petfood & Aquafeed
Source: All Pet Food Magazine


Animal Origin

Animal Origin Category 3 Animal Fat - an important Pet Food Ingredient

2+ MIN

Category 3 Animal Fat - an important Pet Food Ingredient

Animal by-products (ABPs) Animal by-products (ABPs) are materials of animal origin that people do not consume. When they do not enter the human food chain, in Europe, animal by-products are classified into three categories: Category 1, Category 2 and Category 3 depending on the source of the raw material and the intended use[i]. The pet food industry can only use Category 3 ABPs.   Category 3 ABPs are from animals declared fit for human consumption. These are ideal pet food ingredients due to their high nutritional and energetic value and should be used in the best possible way to preserve resources. Category 1 and 2 animal fats are forbidden for animal feeding for safety reasons but allowed for biofuel production.   The Vital role of Category 3 animal fats in Pet Food Category 3 animal fats are essential raw materials for our pets' diets. They provide a source of energy and palatability but above all essential fatty acids. They are subject to strict requirements on sourcing and collecting, animal origin materials processing, and control. Category 3 animal fats cannot be easily replaced as a pet food ingredient.   The EU & The Pet Food Industry's Waste Hierarchy FEDIAF firmly believes that food, such as Category 3 animal fats, which is not intended for human consumption, should be repurposed according to the food waste hierarchy, i.e.:  pet food (re-use animal feed) rather than energy (recovery) as indicated below[ii].  This sits well above energy use in the EU's own hierarchy of most-preferable options for food waste disposal.     The Pet Food Industry and the Future Unfortunately, there is increasing pressure due to Category 3 animal fats being used in other sectors such as biofuels, which are much lower in terms of waste hierarchy.  The Pet Food Industry will continue to communicate the importance of Category 3 animal fats in pet food. They are vital ingredients, which contribute to our circular business model and they cannot easily be replaced.   Source: FEDIAF

Animal Origin Innovative FEED Act introduced in US House of Representatives

3+ MIN

Innovative FEED Act introduced in US House of Representatives

The Innovative Feed Enhancement and Economic Development (Innovative FEED) Act was introduced into the U.S. House of Representatives on December 7, a step toward establishing a regulatory pathway for a new category of animal feed additives. The bill was introduced in the U.S. Senate in June. The Innovative FEED Act would amend the Federal Food, Drug and Cosmetic Act to allow for a new category of animal food substances that act solely within animals' gut microbiomes or in the feed they are digesting to provide a wide range of benefits, giving the U.S. Food and Drug Administration (FDA) the power it needs to ensure regulations keep pace with scientific innovation in feed, the American Feed Industry Association (AFIA) said in a press release. 'The AFIA is excited that the Senate has already introduced the Innovative FEED Act and now, with the House introduction, the bill has the bipartisan and bicameral support we hoped for,' AFIA President and CEO Constance Cullman said. 'Now, we urge Congress to act quickly on the bill. The legislation will be the spark needed to drive nutritional innovation that improves animal health and production while addressing public health challenges. We need this modernized regulatory oversight instead of the current policy of overregulation. Any delay in enacting this legislation continues to put U.S. agriculture at a disadvantage compared to our global counterparts whose regulatory systems have evolved with the times.' The FDA's Center of Veterinary Medicine (CVM) regulates animal foods with drug claims, including environmental benefit or production claims and claims about the effects on the animal's microbiome. Many in the animal feed industry agree CVM's regulations are overly burdensome and that some rules are inconsistent and arbitrary, and that they put U.S. companies at a competitive disadvantage. They also say the regulations put U.S. dairy and beef producers at a disadvantage because they don't have broad access to these methane-reducing feed additives. Dozens of countries have already safely approved and started using these feed ingredients on farms, resulting in improved animal production, well-being, reduced pre-harvest food safety concerns, and a smaller environmental footprint, AFIA said. 'Competent authorities of our global competitors in Europe, Asia and South America already have updated their policies to allow feed products on the market that demonstrate increased efficiency in meat production as well as byproduct and waste reduction,' said David Fairfield, senior vice president of feed at the National Grain and Feed Association, in a statement. 'To compete in the global market, farmers and ranchers in the United States need access to innovative zootechnical animal food substances to improve animal production and well-being, diminish pre-harvest food safety concerns, and boost sustainability opportunities.' The AFIA has urged the FDA to modernize its outdated 1998 Policy and Procedures Manual Guide 1240.3605, which has hindered animal food manufacturers from clearly indicating non-nutritive benefits on labels without navigating the FDA's arduous drug approval process. There is a wide range of feed additives that have been shown to reduce enteric methane emissions by between 2% and 12% per year. These include seaweed, fatty acids, 3-Nitrooxypropanol (3-NOP), oregano, tannins, nitrate, biochar, cinnamon, garlic and saponins. 'These ingredients have novel benefits that make a positive impact on our food production system, such as improving feed efficiency and reducing human foodborne illness," Fairfield said. "This legislation would provide food manufacturers with a pathway to make truthful, non-misleading production, environmental and well-being claims for animal foods that have been substantiated to provide such benefits more efficiently.' The Innovative FEED Act will bring about the necessary changes to ensure these additives are reviewed for safety and effectiveness as food additives, not drugs, and can more quickly come to market for U.S. farmers and ranchers to choose to use, AFIA said.  By AFIA Source . All Pet Food